EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-Data Drug Design with Few-Shot Generative Domain Adaptation

Ke Liu, Yuqiang Han, Zhichen Gong, Hongxia Xu

Bioengineering · 21.09.2023 · 10 (9) · 1104

DOI: 10.3390/bioengineering10091104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering, online erschienen am 21.09.2023. Verfasst von Ke Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science and Technology, Zhejiang University, Hangzhou 310027, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing new drugs for emerging diseases, such as COVID-19, is crucial for promoting public health. In recent years, the application of artificial intelligence (AI) has significantly advanced drug discovery pipelines. Generative models, such as generative adversarial networks (GANs), exhibit the potential for discovering novel drug molecules by relying on a vast number of training samples. However, for new diseases, only a few samples are typically available, posing a significant challenge to learning a generative model that produces both high-quality and diverse molecules under limited supervision. To address this low-data drug generation issue, we propose a novel molecule generative domain adaptation paradigm (Mol-GenDA), which transfers a pre-trained GAN on a large-scale drug molecule dataset to a new disease domain using only a few references. Specifically, we introduce a molecule adaptor into the GAN generator during the fine tuning, allowing the generator to reuse prior knowledge learned in pre-training to the greatest extent and maintain the quality and diversity of the generated molecules. Comprehensive downstream experiments demonstrate that Mol-GenDA can produce high-quality and diverse drug candidates. In summary, the proposed approach offers a promising solution to expedite drug discovery for new diseases, which could lead to the timely development of effective drugs to combat emerging outbreaks.

Schlagwörter

Stichwörter der Autor:innen

domain adaptationdrug designgenerative model

Autor:innen und Institutionen

  • College of Computer Science and Technology, Zhejiang University, Hangzhou 310027, China.
  • ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou 311200, China.
  • Department of Computer Science, University College London, London WC1E 6BT, UK.
  • Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310027, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, K., Han, Y., Gong, Z., & Xu, H. (2023). Low-Data Drug Design with Few-Shot Generative Domain Adaptation. Bioengineering, 10(9), 1104. https://doi.org/10.3390/bioengineering10091104

Vancouver

Liu K, Han Y, Gong Z, Xu H. Low-Data Drug Design with Few-Shot Generative Domain Adaptation. Bioengineering. 2023;10(9):1104. doi:10.3390/bioengineering10091104

BibTeX
@article{Liu2023,
  author = {Liu, Ke and Han, Yuqiang and Gong, Zhichen and Xu, Hongxia},
  title = {Low-Data Drug Design with Few-Shot Generative Domain Adaptation},
  journal = {Bioengineering},
  year = {2023},
  volume = {10},
  number = {9},
  pages = {1104},
  doi = {10.3390/bioengineering10091104}
}
Kostenlos starten →